Virus News and Research

Latest Virus News and Research

Study identifies ORF8 protein as a key COVID-19 causing factor

New study suggests that the SARS-CoV-2 ORF8 protein is the underlying cause behind severe COVID-19 infection.

8 Dec 2021

Interactions between RNA viruses and human RNA-binding proteins

During the virus's attempt to use the host cell to replicate, host proteins interact heavily with the viral genome. Researchers have been investigating these interactions.

8 Dec 2021

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

A team of researchers set out to build a full-length, membrane-embedded spike to study its conformational dynamics at the atomic level using molecular dynamics simulations to understand better how this important component of the virus machinery works.

8 Dec 2021

Impact of COVID-19 on children with complex underlying medical conditions

A new study concludes that children with medical complexities experienced adverse health outcomes during the COVID-19 pandemic.

8 Dec 2021

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Researchers propose an analytical framework and two methodologies for estimating transmission heterogeneity dynamics in this paper.

8 Dec 2021

Brain injury markers associated with dysregulated immunological responses in COVID-19

Study shows that during hospitalization, patients with COVID-19 demonstrated elevated NfL and GFAP in a severity-dependant manner, as well as evidence of ongoing active brain injury 4 months later.

8 Dec 2021

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

A new study has focussed on determining the levels of nAb in individuals who received the second and third doses of the RNA vaccines developed by Pfizer and Moderna.

8 Dec 2021

Combination of vaccination and natural infection offers utmost protection against COVID variants

A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.

8 Dec 2021

Rapid antigen detection test for SARS-CoV-2 proves more effective than expected, large study reports

In what is believed to be the largest prospective study of its kind to date - involving some 6,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a 10-day period around the beginning of 2021 - researchers at Johns Hopkins Medicine, the University of Maryland Medical Center, the University of Maryland School of Medicine and four other collaborators report that a rapid antigen detection test for SARS-CoV-2, the virus that causes COVID-19, proved more effective than expected when compared with virus detection rates using the established standard test, the polymerase chain reaction (PCR) assay.

8 Dec 2021

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

Researchers examine 140 unique SARS-CoV-2 ORF10 sequences among 202,968 ORF10 retrieved sequences.

7 Dec 2021

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

New research reports 4’-Fluorouridine (4′-FlU) as an oral antiviral against RSV and SARS-CoV-2.

7 Dec 2021

Risk assessment of the threat of SARS-CoV-2 on banknotes

A new study evaluates the risk of SARS-CoV-2 exposure by fomite transmission during cash transactions.

7 Dec 2021

SARS-CoV-2 re-infection from new variant after natural infection

Researchers survey incidences of SARS-CoV-2 infection in both care home staff and residents early in the pandemic.

7 Dec 2021

Delays in hospitals' cardiac care services mount during COVID-19 pandemic

Researchers analyzed 94 papers related to the delivery of healthcare services during the COVID-19 pandemic.

7 Dec 2021

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Researchers determine how different the SARS-CoV-2 Delta variant was from the previously dominant Alpha variant.

7 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Virus News and Research

Latest Virus News and Research

Study identifies ORF8 protein as a key COVID-19 causing factor

Interactions between RNA viruses and human RNA-binding proteins

Equilibrium simulation of SARS-CoV-2 spike protein highlights its global conformational characteristics

Impact of COVID-19 on children with complex underlying medical conditions

Estimating transmission heterogeneity dynamics of SARS-CoV-2 in Massachusetts

Brain injury markers associated with dysregulated immunological responses in COVID-19

Does a COVID-19 vaccine booster improve the immune response of a poor responder?

Combination of vaccination and natural infection offers utmost protection against COVID variants

Rapid antigen detection test for SARS-CoV-2 proves more effective than expected, large study reports

ORF10 protein mutations alter SARS-CoV-2 pathogenicity

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

Risk assessment of the threat of SARS-CoV-2 on banknotes

SARS-CoV-2 re-infection from new variant after natural infection

Delays in hospitals' cardiac care services mount during COVID-19 pandemic

Delta SARS-CoV-2 variant drove increase in infection numbers in the U.K.

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Community mask usage reduces symptomatic COVID seroprevalence in Bangladesh

Study: European governments struggled to maintain public trust during the pandemic

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in